Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic phenylephrine dosing for prevention of hypotension after spinal anesthesia in hypertensive disorders of pregnancy undergoing cesarean section
TCTR20221028001Phase 4Unknown
- Sponsor
- N/A
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenylephrine in maternal hypertension (HDP), sponsored by N/A. Status: unknown.
02
Drugs
phenylephrine
03
Conditions
maternal hypertension (HDP)
Beyond the preview
Go deeper on TCTR20221028001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221028001.